
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study
Keywords: Acromegaly; Lanreotide; Cabergoline; Pegvisomant; IGF-I; Somatostatin analogues; Acromegalia; Lanreotida; Cabergolina; Pegvisomant; IGF-I; Análogos de la somatostatina;